课题基金 / 基金详情

NEW HIRES

NEW HIRES
新员工
批准号:
8167880
负责人:
ALEXANDER V KABANOV
金额:
$30.04万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-07-01 至 2011-06-30

项目摘要

项目成果

ALEXANDER V KABANOV的其他基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金, 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 NCN教师招聘部分旨在为中心提供足够多的研究人员和技术,使其成为具有竞争力的、多产的研究企业。这将通过有针对性地招聘关键教员来实现,这些教员将带来中心目前没有的相关新研究内容。这是产生一个真正的多学科纳米医学研究企业所必需的。这些有针对性的招聘带来了神经肿瘤学、纳米材料药理学和显像剂输送方面的协同效应和专业知识。这些有重点的招聘对于NCN的成功以及使该中心成为一个具有高持续成功可能性的综合生物医学研究企业至关重要。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The NCN faculty recruitment component is designed to achieve the critical mass of researchers and technologies for the Center to function as a competitive, productive research enterprise. This will be accomplished by targeted recruitment of key faculty who will bring relevant new research components not currently present at the Center. This is necessary to produce a truly multidisciplinary research enterprise in nanomedicine. These targeted hires bring synergy and expertise in neurooncology, nanomaterials pharmacology, and delivery of imaging agents. These focused hires are essential for the success of the NCN and for making the Center an integrated biomedical research enterprise with a high likelihood of sustained success.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Naturally Targeted Exosomal TLR7/8 Agonist for Immunotherapy of Medulloblastoma
  • 批准号:
    10790660
  • 项目类别:
  • 资助金额:
    $42.76万
  • 财政年份:
    2023
  • 负责人:
    ALEXANDER V KABANOV
  • 依托单位:
TOWARD TRANSLATION OF NANFORMULATED PACLITAXEL-PLATINUM COMBINATION
  • 批准号:
    10436355
  • 项目类别:
  • 资助金额:
    $60.08万
  • 财政年份:
    2021
  • 负责人:
    ALEXANDER V KABANOV
  • 依托单位:
TOWARD TRANSLATION OF NANFORMULATED PACLITAXEL-PLATINUM COMBINATION
  • 批准号:
    10684815
  • 项目类别:
  • 资助金额:
    $49.63万
  • 财政年份:
    2021
  • 负责人:
    ALEXANDER V KABANOV
  • 依托单位:
TOWARD TRANSLATION OF NANFORMULATED PACLITAXEL-PLATINUM COMBINATION
  • 批准号:
    10621403
  • 项目类别:
  • 资助金额:
    $11.79万
  • 财政年份:
    2021
  • 负责人:
    ALEXANDER V KABANOV
  • 依托单位: